All News


All series


All All News

VYXEOS (CPX-351), a novel injection, was granted a new drug application (NDA) by the Food and Drug Administration (FDA), granting the drug a priority review for the treatment of acute myeloid leukemia (AML), according to Jazz Pharmaceuticals, the producer of the drug.

We’re all so busy and stressed with personal, medical, financial and professional responsibilities. This stress can have a real biological effect on our bodies that we should try to manage.